NASDAQ:SYRE | EBITDA Margin | Spyre Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2016-12-31 to 2023-12-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2023-03-31-9304.04%
2022-12-31-11176.79%
2022-03-31-1764.90%
2021-12-31-549.70%
2018-03-31-541.39%
2017-12-31-442.65%

Annual EBITDA Margin

DateEBITDA Margin
2023-12-31-27264.00%
2022-12-31-3572.95%
2021-12-31-341.92%
2018-12-31-1161.78%
2017-12-31-526.94%
2016-12-31-470.48%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.